Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Molecular therapy for acute respiratory distress syndrome: SMAD7 inhibits acute lung injury via down regulation of its target gene, 16/April/2015, 23.10, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that SMAD7 , by suppressing the expression of its target gene, it may inhibit acute lung injury. Thereby, it may inhibit the progression of acute respiratory distress syndrome. Thus, pharmacological formulations encompassing “SMAD7 activators“ may be used to inhibit the progression of acute respiratory distress syndrome.
Amount: $ 300
Undisclosed information: How SMAD7 inhibits the progression of acute respiratory distress syndrome
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org